G
Giulia Arrivi
Researcher at Sapienza University of Rome
Publications - 18
Citations - 84
Giulia Arrivi is an academic researcher from Sapienza University of Rome. The author has contributed to research in topics: Medicine & Colorectal cancer. The author has an hindex of 3, co-authored 7 publications receiving 33 citations.
Papers
More filters
Journal ArticleDOI
Multidisciplinary Management of Neuroendocrine Neoplasia: A Real-World Experience from a Referral Center.
Ludovica Magi,Federica Mazzuca,Maria Rinzivillo,Giulia Arrivi,Emanuela Pilozzi,Daniela Prosperi,Elsa Iannicelli,Paolo Mercantini,Michele Rossi,Patrizia Pizzichini,Andrea Laghi,Alberto Signore,Paolo Marchetti,Bruno Annibale,Francesco Panzuto +14 more
TL;DR: Multidisciplinary approach in a dedicated team may lead to change of disease imaging staging and grading in a significant proportion of patients, since it may improve patients’ clinical outcome.
Journal ArticleDOI
Clinical Impact of Highly Purified, Whey Proteins in Patients Affected With Colorectal Cancer Undergoing Chemotherapy: Preliminary Results of a Placebo-Controlled Study.
Federica Mazzuca,Michela Roberto,Giulia Arrivi,Elena Sarfati,Francesca Matilde Schipilliti,Edoardo Crimini,Andrea Botticelli,Marco Di Girolamo,Maurizio Muscaritoli,Paolo Marchetti +9 more
TL;DR: It is shown how whey protein could be an important therapeutic option to improve nutritional status, and particularly to prevent severe toxicity during chemotherapy, as well as significantly predictive of chemotherapy toxicity.
Journal ArticleDOI
Electrochemotherapy for Solid Tumors: Literature Review and Presentation of a Novel Endoscopic Approach
Francesca Matilde Schipilliti,M Onorato,Giulia Arrivi,Martina Panebianco,Debora Lerinò,Annalisa Milano,Michela Roberto,Carlo Capalbo,Federica Mazzuca +8 more
TL;DR: The combination of systemic treatment and ECT was safe and highly effective in the treatment of colorectal cancer, especially when obstructive, giving the patient a significant gain in quality of life.
Journal ArticleDOI
Electrochemotherapy as Promising Treatment Option in Rare Recurrent Cutaneous Neoplasm of the Scalp: Case Report of an Elderly Patient.
Edoardo Crimini,Michela Roberto,Valter Degli Effetti,Paolo Marchetti,Andrea Botticelli,Francesca Matilde Schipilliti,Giulia Arrivi,Federica Mazzuca +7 more
TL;DR: ECT showed to be an effective and safe treatment for recurrent neoplasms of the head and neck, considering the complete response obtained and the absence of disease relapse after two years, the first case report that shows great clinical results using ECT after surgery in relapsed AFX/PDS.
Journal ArticleDOI
The treatment paradigm of right-sided metastatic colon cancer: harboring BRAF mutation makes the difference.
Michela Roberto,Paolo Marchetti,Giulia Arrivi,Francesca Di Pietro,Stefano Cascinu,Fabio Gelsomino,Francesco Caputo,Krisida Cerma,Michele Ghidini,Margherita Ratti,Claudio Pizzo,Corrado Ficorella,Alessandro Parisi,Alessio Cortellini,Federica Urbano,Maria Letizia Calandrella,Andrea Botticelli,Emanuela Dell'Aquila,Alessandro Minelli,Claudia Angela Maria Fulgenzi,Andrea Montori,Emanuela Pilozzi,Federica Mazzuca +22 more
TL;DR: It is demonstrated that BRAF status makes the difference in treatment’s outcome, and the anti-EGFR should not be excluded in all advanced RCC but considered on a case-by-case basis.